Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Titertek-Berthold was a life science tools and laboratory instrumentation company formed in 2011 by combining Titertek Instruments, Inc. and Berthold Detection Systems GmbH. The business focused on developing, manufacturing, and distributing bench-top instruments and automation systems for life science, biomedical, pharmaceutical, biotechnology, and diagnostics laboratories. Its portfolio included microplate readers, luminometers, ELISA workstations, washers, dispensers, microvolume spectrometers, gamma counters, and related lab automation products. In 2017, Titertek-Berthold / Berthold Detection Systems joined forces with Berthold Technologies, and the brand now appears to be absorbed into Berthold Technologies' Bioanalytics business, with Titertek-Berthold listed among owned or discontinued brands rather than as a standalone active operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Titertek-Berthold.